Treatment of African trypanosomiasis with cordycepin and adenosine deaminase inhibitors in a mouse model

Journal of Infectious Diseases

Volumn 192, Issue 9, 2005, Pages 1658-1665

  Rottenberg, Martin E ^a   Masocha, Willias ^b   Ferella, Marcela ^b   Petitto Assis, Fabricio ^c   Goto, Hiro ^c   Kristensson, Krister ^b   McCaffrey, Ronald ^d   Wigzell, Hans ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE INHIBITOR; ADENOSINE DERIVATIVE; CD45 ANTIGEN; COFORMYCIN; CORDYCEPIN; OVALBUMIN; PENTOSTATIN;

AFRICAN TRYPANOSOMIASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRAIN BLOOD VESSEL; BRAIN TISSUE; CONTROLLED STUDY; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATORY CELL; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PARASITEMIA; PARENCHYMA; PRIORITY JOURNAL; TRYPANOSOMA BRUCEI; VASCULAR ENDOTHELIUM; WASTING SYNDROME;

EID: 27144556166     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/496896     Document Type: Article

References (30)

1. Barrett MP. The fall and rise of sleeping sickness. Lancet 1999; 353:1113-4.
2. Pepin J, Milord F. The treatment of human African trypanosomiasis. Adv Parasitol 1994; 33:1-47.
3. Bacchi CJ, Nathan HC, Hutner SH, McCann PP, Sjoerdsma A. Polyamine metabolism: a potential therapeutic target in trypanosomes. Science 1980; 210:332-4.
4. Brun R, Schumacher R, Schmid C, Kunz C, Burri C. The phenomenon of treatment failures in Human African Trypanosomiasis. Trop Med Int Health 2001; 6:906-14.
5. Agarwal RP, Sagar SM, Parks RE Jr. Adenosine deaminase from human erythrocytes: purification and effects of adenosine analogs. Biochem Pharmacol 1975; 24:693-701.
6. Hammond DJ, Gutteridge WE. Purine and pyrimidine metabolism in the trypanosomatidae. Mol Biochem Parasitol 1984; 13:243-61.
7. Hassan HF, Coombs GH. Purine and pyrimidine metabolism in parasitic protozoa. FEMS Microbiol Rev 1988; 4:47-83.
8. James DM, Born GV. Uptake of purine bases and nucleosides in African trypanosomes. Parasitology 1980; 81:383-93.
9. Baltz T, Baltz D, Giroud C, Crockett J. Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO J 1985; 4:1273-7.
10. Hirumi H, Hirumi K. Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. J Parasitol 1989; 75:985-9.
11. Lanham SM, Godfrey DG. Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp Parasitol 1970; 28:521-34.
12. Masocha W, Robertson B, Rottenberg ME, Mhlanga J, Sorokin L, Kristensson K. Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrier. J Clin Invest 2004; 114:689-94.
13. Mulenga C, Mhlanga JD, Kristensson K, Robertson B. Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model. Neuropathol Appl Neurobiol 2001; 27:77-85.
14. Adamson RH, Zaharevitz DW, Johns DG. Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2′-deoxycoformycin. Pharmacology 1977; 15:84-9.
15. Johns DG, Adamson RH. Enhancement of the biological activity of cordycepin (3′-deoxyadenosine) by the adenosine deaminase inhibitor 2′-deoxycoformycin. Biochem Pharmacol 1976; 25:1441-4.
16. Spigelman Z, Duff R, Beardsley GP, et al. 2′,3′- Dideoxyadenosine is selectively toxic for TdT-positive cells. Blood 1988; 71:1601-8.
17. Williamson J. Further experiments with the nucleoside trypanocide, cordycepin. Trans R Soc Trop Med Hyg 1972; 66:354-5.
18. Aiyedun BA, Williamson J, Amodu AA. The effect of cordycepin on tsetse-borne Trypanosoma vivax infections. Acta Trop 1973; 30:276-8.
19. Williamson J, Macadam RF. Drug effects on the fine structure of Trypanosoma rhodesiense: puromycin and its aminonucleoside, Cordycepin and Nucleocidin. Trans R Soc Trop Med Hyg 1976; 70:130-7.
20. Maser P, Vogel D, Schmid C, Raz B, Kaminsky R. Identification and characterization of trypanocides by functional expression of an adenosine transporter from Trypanosoma brucei in yeast. J Mol Med 2001; 79:121-7.
21. Griffith DA, Jarvis SM. Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1996; 1286:153-81.
22. Williamson J, Scott-Finnigan TJ. Trypanocidal activity of antitumor antibiotics and other metabolic inhibitors. Antimicrob Agents Chemother 1978; 13:735-44.
23. Kennedy PG. Human African trypanosomiasis of the CNS: current issues and challenges. J Clin Invest 2004; 113:496-504.
24. Koc Y, Urbano AG, Sweeney EB, McCaffrey R. Induction of apoptosis by cordycepin in ADA-inhibited TdT-positive leukemia cells. Leukemia 1996; 10:1019-24.
25. Kodama EN, McCaffrey RP, Yusa K, Mitsuya H. Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells. Biochem Pharmacol 2000; 59:273-81.
26. Bogue M, Gilfillan S, Benoist C, Mathis D. Regulation of N-region diversity in antigen receptors through thymocyte differentiation and thymus ontogeny. Proc Natl Acad Sci USA 1992; 89:11011-5.
27. Desiderio SV, Yancopoulos GD, Paskind M, et al. Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature 1984; 311:752-5.
28. Yancopoulos GD, Blackwell TK, Suh H, Hood L, Alt FW. Introduced T cell receptor variable region gene segments recombine in pre-B cells: evidence that B and T cells use a common recombinase. Cell 1986; 44:251-9.
29. Lamanna N, Weiss M. Purine analogs in leukemia. Adv Pharmacol 2004; 51:107-25.
30. Pettitt AR. Mechanism of action of purine analogues in chronic lymphocytic leukaemia. Br J Haematol 2003; 121:692-702.